Patent · US Expired

VEGF peptides and their use for inhibiting angiogenesis

US7223835B2 · kind B2 · utility

1Cited by
0References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2001
Grant dateMay 29, 2007
Priority date
Expiry dateJun 12, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A peptide having part or all of the amino acid sequence QKRKRKKSRYKSWSVP (which is part of VEGF) has the ability to inhibit angiogenesis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.